IBO vs MGM · rev $10.0K vs P/E 64, rev $4.45B
Impact BioMedical, Inc. (IBO) versus MGM Resorts International (MGM) — a side-by-side from cached financials, not a winner call.
Impact BioMedical, Inc. (IBO) is a biotechnology company listed on US.
MGM Resorts International (MGM) is a resorts & casinos company listed on NYSE.
Latest reported IBO revenue for 2026-06-30 was $10.0K. Net income was -$3.0M. Revenue was up 42.9% from 2026-03-31 to 2026-06-30. IBO currently screens at market cap $7.6M.
Latest reported MGM revenue for 2026-06-30 was $4.45B. Net income was $292.4M. Revenue was down 0.1% from 2026-03-31 to 2026-06-30. MGM currently screens at market cap $12.01B and trailing P/E 64.3.
IBO currently screens at market cap $7.6M. MGM currently screens at market cap $12.01B and trailing P/E 64.3.
Not investment advice. Open the IBO and MGM stock pages for the full models.
Not investment advice.